Skip to main content

Table 3 Site characteristics overview

From: Implementing a pharmacist-integrated collaborative model of medication treatment for opioid use disorder in primary care: study design and methodological considerations

 

Site A

Site B

Site C

Site D

Site location

New Hampshire

Utah

Washington

New Mexico

Area

Medicaid expansion

Medicaid coverage for MOUD

HRSA-designated shortage area

Medicaid expansion

Medicaid coverage for MOUD

Medicaid expansion

Medicaid coverage for MOUD

HRSA-designated shortage area

Medicaid expansion

Medicaid coverage for MOUD

HRSA-designated shortage area

Primary care clinic type

FQHC

Hospital/medical center

FQHC

Hospital/medical center

Unique primary care patients

2681

19,265

9488 patients

1900

Unique MOUD patients

350

123

221

35

Unique primary care prescribers (any Rx)

4

26

54

9

Unique MOUD prescribers

5

4

48

7

MOUD options

Buprenorphine

Buprenorphine/naloxone

Extended-release buprenorphine

Naltrexone

Extended-release naltrexone

Buprenorphine

Buprenorphine/naloxone

Extended-release buprenorphine

Naltrexone

Extended-release naltrexone

Buprenorphine

Buprenorphine/naloxone

Extended-release buprenorphine

Naltrexone

Extended-release naltrexone

Buprenorphine

Buprenorphine/naloxone

Extended-release buprenorphine

Naltrexone

Extended-release naltrexone

Clinic characteristics

• Staffing includes MD, advanced practice practitioners, RN, behavioral health, social workers, or recovery coach presence

• No DO, residents

• Serves unhoused and formerly incarcerated people

• Close collaboration approaching an integrated practice

• Staffing includes MD, Residents, advanced practice practitioners, RN, social work, and recovery coaching

• No DO or behavioral health presence

• Established referral system from other medical center departments (e.g., emergency)

• Close collaboration approaching an integrated practice

• Staffing includes MD, DO, Residents, advanced practice practitioners, RN, behavioral health

• MOUD patient coordinator

• No recovery coach presence

• Serves unhoused population

• Full collaboration in a transformed/merged integrated practice

• Staffing includes MD, DO, Residents, advanced practice practitioners, RN, behavioral health, social work

• No recovery coach presence

• Serves transgender/non-binary, unhoused, and people in treatment for infectious disease

• Full collaboration in a transformed/merged integrated practice

Pharmacy characteristics

• 19,789 prescriptions filled

• 2 pharmacists, 2 pharmacy techs

• 340B member

• Retail pharmacy on-site

• No established clinical pharmacist role

• 120,630 prescriptions filled

• 5 pharmacists, 9 pharmacy techs

• Ambulatory care pharmacy team includes 1 pharmacist and 1 technician

• 340B member

• Retail pharmacy on-site

• Embedded clinical pharmacist in family and internal medicine

• Offsite clinical manager oversees ambulatory care pharmacists, pharmacy resident, and embedded clinic pharmacy technician

• 41,599 prescriptions filled

• 2 pharmacists, 2 pharmacy techs

• 340B member

• Retail pharmacy on-site/nearby

• Clinical pharmacist sees patients with other chronic diseases (e.g., hypertension, diabetes)

• Carries extended-release buprenorphine and HIV medications for specialty clinics onsite

• ~ 72,000 prescriptions filled

• 4 pharmacists, 8 pharmacy techs

• 340B member

• Retail pharmacy on-site

• Clinical pharmacist sees people with HIV, HepC, and those with metabolic issues

• Pharmacists have prescriptive authority to prescribe and dispense Narcan; clinic-based extended-release buprenorphine